chondroitin sulfate-steroid conjugate (SI-722) / Seikagaku - LARVOL DELTA

PK and Safety of SI-722 in IC/BPS (clinicaltrials.gov) - P1/2; N=33; Completed; Sponsor: Seikagaku Corporation; Active, not recruiting ➔ Completed

Clinical • Trial completion • Interstitial Cystitis • Musculoskeletal Pain • Pain

PK and Safety of SI-722 in IC/BPS (clinicaltrials.gov) - P1/2; N=33; Active, not recruiting; Sponsor: Seikagaku Corporation; Recruiting ➔ Active, not recruiting

Clinical • Enrollment closed • Interstitial Cystitis • Musculoskeletal Pain • Pain

PK and Safety of SI-722 in IC/BPS (clinicaltrials.gov) - P1/2; N=32; Recruiting; Sponsor: Seikagaku Corporation; Not yet recruiting ➔ Recruiting; Trial completion date: Aug 2020 ➔ Feb 2021; Trial primary completion date: Aug 2020 ➔ Feb 2021

Clinical • Enrollment open • Trial completion date • Trial primary completion date • Interstitial Cystitis • Pain